BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35239524)

  • 1. Prognostic Factors of Bone Metastases From Colorectal Cancer in the Era of Targeted Therapy.
    Kobayashi Y; Shida D; Boku N; Yasui K; Nakamura Y; Kudose Y; Imaizumi J; Kanemitsu Y
    Dis Colon Rectum; 2023 Mar; 66(3):401-409. PubMed ID: 35239524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte-to-C-Reactive Protein Ratio Is the Most Sensitive Inflammation-Based Prognostic Score in Patients With Unresectable Metastatic Colorectal Cancer.
    Nakamura Y; Shida D; Boku N; Yoshida T; Tanabe T; Takamizawa Y; Takashima A; Kanemitsu Y
    Dis Colon Rectum; 2021 Nov; 64(11):1331-1341. PubMed ID: 34623347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: 8-Year Single-Institutional Experience.
    Narasimhan V; Britto M; Pham T; Warrier S; Naik A; Lynch AC; Michael M; Tie J; Ramsay R; Heriot A
    Dis Colon Rectum; 2019 Oct; 62(10):1195-1203. PubMed ID: 31490828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Tumor-Related Complications Among Patients With Unresectable Stage IV Colorectal Cancer in the Era of Targeted Therapy: A Competing Risk Regression Analysis.
    Tanabe T; Shida D; Boku N; Yoshida T; Tsukamoto S; Takashima A; Kanemitsu Y
    Dis Colon Rectum; 2021 Sep; 64(9):1074-1082. PubMed ID: 34397558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and Outcomes of Right- Versus Left-Sided Early-Onset Colorectal Cancer.
    Tom CM; Mankarious MM; Jeganathan NA; Deutsch M; Koltun WA; Berg AS; Scow JS
    Dis Colon Rectum; 2023 Apr; 66(4):498-510. PubMed ID: 35001052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naples Prognostic Score Is a Useful Prognostic Marker in Patients With Metastatic Colorectal Cancer.
    Miyamoto Y; Hiyoshi Y; Daitoku N; Okadome K; Sakamoto Y; Yamashita K; Kuroda D; Sawayama H; Iwatsuki M; Baba Y; Yoshida N; Baba H
    Dis Colon Rectum; 2019 Dec; 62(12):1485-1493. PubMed ID: 31567920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of Venous Invasion Detected by Elastin Stain May Surpass Lymph Node Status in Colon Cancer.
    Kim HJ; Choi GS; Seo AN; Park JS; Park SY; Cho SH; Yoon G
    Dis Colon Rectum; 2021 Aug; 64(8):955-963. PubMed ID: 33938533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Significant Polyp and Early Colorectal Cancer Is Optimized by Implementation of a Dedicated Multidisciplinary Team Meeting: Lessons Learned From the United Kingdom National Program.
    Di Fabio F; Jitsumura M; Longstaff L; Krishnamurthy Venkatasubramaniam A; Arnold SJ; Moran B
    Dis Colon Rectum; 2022 May; 65(5):654-662. PubMed ID: 34840306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age Determines Adjuvant Chemotherapy Use in Resected Stage II Colon Cancer.
    Hagerty BL; Aversa JG; Dominguez DA; Davis JL; Hernandez JM; McCormick JT; Blakely AM
    Dis Colon Rectum; 2022 Oct; 65(10):1206-1214. PubMed ID: 34897212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perineural Invasion Is a Prognostic but not a Predictive Factor in Nonmetastatic Colon Cancer.
    Leijssen LGJ; Dinaux AM; Taylor MS; Deshpande V; Kunitake H; Bordeianou LG; Berger DL
    Dis Colon Rectum; 2019 Oct; 62(10):1212-1221. PubMed ID: 31490830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Role for Primary Tumor Location in Patients With Colorectal Liver Metastases: A Comparison of Right-Sided Colon, Left-Sided Colon, and Rectum.
    Takamizawa Y; Shida D; Horie T; Tsukamoto S; Esaki M; Shimada K; Kondo T; Kanemitsu Y
    Dis Colon Rectum; 2023 Feb; 66(2):233-242. PubMed ID: 35714342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Characteristics of Patients With Colorectal Cancer Who Have Benign Mesenteric Lymph Node Enlargement: A Multi-institutional Cohort Study.
    Huang X; Yang Y; Liu Q; Tang X; Shi J; Qu H; Chen X; Gong L; Wang S; Tang S; Wang P; Tang L; Hu D; Yin X; Guan Y; Kong D; Tian F
    Dis Colon Rectum; 2022 Jun; 65(6):804-816. PubMed ID: 34759241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Favorable Survival After Screening for Young-Onset Colorectal Cancer: Benefits of Screening in Young Adults.
    Takada K; Hotta K; Imai K; Ito S; Kishida Y; Ono H
    Dis Colon Rectum; 2022 Aug; 65(8):996-1004. PubMed ID: 34856591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative Nutritional Scores as Host-Related Prognostic Factors for Both Overall Survival and Postoperative Complications in Patients With Stage II to III Colorectal Cancer.
    Ahiko Y; Shida D; Nakamura Y; Imaizumi J; Takamizawa Y; Moritani K; Tsukamoto S; Kanemitsu Y
    Dis Colon Rectum; 2021 Oct; 64(10):1222-1231. PubMed ID: 33951689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Decision Support for High-Risk Stage II Colon Cancer: A Real-World Study of Treatment Concordance and Survival.
    Chen PJ; Li TL; Sun TT; Willis VC; Roebuck MC; Bravata DM; Liu XZ; Arriaga YE; Dankwa-Mullan I; Wu AW
    Dis Colon Rectum; 2020 Oct; 63(10):1383-1392. PubMed ID: 32969881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High World Heath Organization Performance Status Is Associated With Short- and Long-term Outcomes After Colorectal Cancer Surgery: A Nationwide Population-Based Study.
    Bojesen RD; Degett TH; Dalton SO; Gögenur I
    Dis Colon Rectum; 2021 Jul; 64(7):851-860. PubMed ID: 34086001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological Characteristics of Anastomotic Recurrence After Curative Resection for Colorectal Cancer: Comparison With Nonanastomotic Local Recurrences.
    Matsunaga K; Sasaki K; Nozawa H; Kawai K; Murono K; Emoto S; Kishikawa J; Ozawa T; Yokoyama Y; Abe S; Nagai Y; Anzai H; Sonoda H; Hata K; Ishihara S
    Dis Colon Rectum; 2023 Oct; 66(10):e1014-e1022. PubMed ID: 36649156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Size Criteria Is Not Sufficient in Selecting Patients for Local Excision Versus Radical Excision for Rectal Neuroendocrine Tumors >2 cm: A National Cancer Database Analysis.
    Izquierdo KM; Humphries MD; Farkas LM
    Dis Colon Rectum; 2021 Apr; 64(4):399-408. PubMed ID: 33651006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Marker Trajectories and Survival Analysis in Patients With Normal Carcinoembryonic Antigen Ranges After Colorectal Cancer Resection.
    Chern YJ; Hsu HY; Hsu YJ; Hsu LY; Tsai WS; Liao CK; Jong BK; You JF
    Dis Colon Rectum; 2024 Jan; 67(1):62-72. PubMed ID: 37594896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Significance of Preoperative and Postoperative Serum CEA and Carbohydrate Antigen 19-9 Levels in Patients Undergoing Curative Resection of Locally Recurrent Rectal Cancer.
    Paku M; Uemura M; Kitakaze M; Miyoshi N; Takahashi H; Mizushima T; Doki Y; Eguchi H
    Dis Colon Rectum; 2023 Mar; 66(3):392-400. PubMed ID: 36649161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.